![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 15, 8470-8478, 05, 1990
E Chu, JC Drake, D Boarman, J Baram and CJ Allegra
We have studied the roles of 5,10-methylenetetrahydrofolate (5,10-
methylene-H4PteGlu) depletion and dihydrofolate (H2PteGlu) accumulation in
the inhibition of de novo thymidylate synthesis by methotrexate (MTX) in
human MCF-7 breast cancer cells. Using both a high pressure liquid
chromatography system and a modification of the 5-fluoro-2'-
deoxyuridine-5'-monophosphate radioenzymatic binding assay, we determined
that the 5,10-methylene-H4PteGlu pool is 50-60% depleted in human MCF-7
breast cancer cells following exposure to 1 micron MTX for up to 21 h.
Similar alterations in the 5,10-methylene-H4PteGlu pools were obtained when
human promyelocytic HL-60 leukemia cells and normal human myeloid precursor
cells were incubated with 1 micron MTX. The H2PteGlu pools within the MCF-7
cells increased significantly after 15 min of 1 micron MTX exposure,
reaching maximal levels by 60 min. Thymidylate synthesis, as measured by
labeled deoxyuridine incorporation into DNA, decreased to less than 20% of
control activity within 30 min of 1 micron MTX exposure. The inhibition of
thymidylate synthesis coincided temporally with the rapid intracellular
accumulation of H2PteGlu, a known inhibitor of thymidylate synthase.
Furthermore, inhibition of this pathway was associated in a log-linear
fashion with the intracellular level of dihydrofolate. These studies
provide further evidence that depletion of the thymidylate synthase
substrate 5,10-methylene-H4PteGlu is inadequate to account completely for
diminished thymidylate synthesis resulting from MTX treatment. Our findings
suggest that acute inhibition of de novo thymidylate synthesis is a
multifactorial process consisting of partial substrate depletion and direct
enzymatic inhibition by H2PteGlu polyglutamates.
Mechanism of thymidylate synthase inhibition by methotrexate in human neoplastic cell lines and normal human myeloid progenitor cells
Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Ulrich, Y. Yasui, R. Storb, M. M. Schubert, J. L. Wagner, J. Bigler, K. S. Ariail, C. L. Keener, S. Li, H. Liu, et al. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism Blood, July 1, 2001; 98(1): 231 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Izeradjene, J.-P. Revillard, and L. Genestier Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells Int. Immunol., January 1, 2001; 13(1): 85 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Carson and J. E. Buster Ectopic Pregnancy N. Engl. J. Med., October 14, 1993; 329(16): 1174 - 1181. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |